http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2444512-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8313c1fb6eab4f679f2b3bc44883f69
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-10
filingDate 2010-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9cd5e7556f74efac6f0c4eb8515c060
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5818c1fe1179922fc86edaab851f4ae2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ce40f22222d4310f283edc630078a7c
publicationDate 2012-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2444512-C1
titleOfInvention Method of producing 2,7-bis[2-(diethyamino)ethoxy]-fluorenone-9 dihydrochloride
abstract FIELD: chemistry. n SUBSTANCE: invention relates to an improved method of producing 2,7-bis-[2-(diethylamino)ethoxy]-fluorenone-9 dihydrochloride, having immunomodulating properties and a wide range of antiviral action. The method of producing 2,7-bis-[2-(diethylamino)ethoxy]-fluorenone-9 dihydrochloride involves sulphonation of fluorene, oxidative hydroxylation of a disodium salt of 2,7- fluorene disulphonic acid, cyclisation of 4,4'-dihydroxydiphenyl-2-carboxylic acid, alkylation of 2,7-dihydroxyfluorenone with treatment of the obtained alkylated product with concentrated hydrochloric acid. The obtained product undergoes solvent refining through re-extraction of the alkylated product in an aqueous solution treated with hydrochloric acid to obtain a chloride salt of 2,7-bis-[2-(diethylamino)ethoxy]-fluorenone-9, from which nonpolar impurities are washed off using toluene solution and after treatment with alkali, the obtained phases are separated with extraction of 2,7-bis-[2-(diethylamino)ethoxy]-fluorenone-9 into an organic phase. The latter is washed with water in order to remove polar impurities and the product is converted to a chloride salt by treatment with concentrated hydrochloric acid in molar ratio 1:3.5-1:4. Said extraction steps can be carried 1-3 times. n EFFECT: method enables to cut the number of process operations at the purification step, cut solvent consumption and obtain a high-quality product with 99,85-99,90% content of basic substance. n 1 tbl, 1 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2521595-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2707176-C1
priorityDate 2010-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2218327-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2317976-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2003121101-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2076097-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2317974-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423109206
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19902020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538250
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432040831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5475
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136365795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23367467
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141233
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID35842
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422742828
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411626879
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415721635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID650
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21255859
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28557
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2060084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410491760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433242730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154487590
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448434921
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393768
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450013033
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12283177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416138595
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13364
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393764
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 57.